Oslo, Norway, 5 June 2020
Reference is made to the stock exchange announcement published by Ultimovacs ASA (the “Company”) on 28 May 2020 regarding the successful placing of a private placement with gross proceeds of approximately NOK 160 million (the “Private Placement”).
The share capital increase related to Private Placement has been registered with the Norwegian Register of Business Enterprises. Following such registration, the share capital of the Company is NOK 3,197,351.10, divided into 31,973,511 shares, each with a par value of NOK 0.10.
This information is subject of the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.
For further information, please visit www.ultimovacs.com or contact:
Carlos de Sousa, CEO Email: carlos.desousa@ultimovacs.com Phone: +47 908 92507 Hans Vassgård Eid, CFO Email: hans.eid@ultimovacs.com Phone: +47 482 48632